Randomized controlled trial of intravesical electrical stimulation for underactive bladder
- 2 October 2022
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 131 (3) , 321-329
Abstract
Aim: To evaluate the efficacy and safety of intravesical electrical stimulation (IVES) performed with a novel device in patients with underactive bladder (UAB). Patients and Methods: This was a multicentre, prospective, single‐blind, randomized controlled clinical trial of patients with UAB in China. Eligible patients were randomly assigned in a 1:1 ratio to receive conventional IVES ( n = 38) or IVES with an open circuit ( n = 38). The primary efficacy measure was change from baseline in post‐void residual urine volume (PVR) after 4 weeks of treatment. Secondary efficacy measures included changes in maximum urinary flow rate ( Q max ), bladder voiding efficiency (BVE), number of 24‐h clean intermittent catheterization (CIC) procedures, and Patient Perception of Bladder Condition‐Scale (PPBC‐S) and American Urological Association Symptom Index Quality of Life (AUA‐SI‐QoL) scores from baseline after 4 weeks of treatment. Adverse events (AEs) were monitored throughout the trial. Results: In the full analysis set (FAS), the mean ( sd ) PVR changes in the trial and control groups at 4 weeks were −97.1 (107.5) mL and −10.5 (86.7) mL, respectively ( P < 0.01). Similar results were obtained in the per‐protocol set (PPS): −102.9 (100.0) mL vs 0.7 (82.5) mL ( P < 0.01). In the FAS and PPS, Q max improved significantly at 4 weeks ( P = 0.04 and P = 0.03). In the FAS and PPS, BVE was significantly improved at 4 weeks in the two groups ( P < 0.01 and P < 0.01), whereas no significant differences in the number of 24‐h CIC procedures, PPBC‐S score or AUA‐SI‐QoL score were observed between the groups. Six possible therapy‐related AEs occurred in six patients (four in the trial group and two in the control group; P = 0.67), all of which were urinary tract infections. No severe AEs were reported. Conclusions: The results of this clinical study strongly demonstrate that UAB patients benefit from this novel IVES device. More research is needed to validate the clinical utility of this device.Keywords
Funding Information
- National Key Research and Development Program of China (2018YFC2002203)
This publication has 22 references indexed in Scilit:
- Prevalence and Clinical Features of Detrusor Underactivity among Elderly with Lower Urinary Tract Symptoms: A Comparison between Men and WomenKorean Journal of Urology, 2012
- Exploring the mechanisms of intravesical electrical stimulation in the in vitro rat whole bladder after treatment with atropine, α,β‐methylATP and tetrodotoxinNeurourology and Urodynamics, 2010
- Afferent Nerve Regulation of Bladder Function in Health and Disease2009
- Conservative Treatment of Patients with Neurogenic BladderEuropean Urology Supplements, 2008
- The neural control of micturitionNature Reviews Neuroscience, 2008
- Intravesical Electrotherapy for Neurogenic Bladder Dysfunction: A 22-Year ExperienceJournal of Urology, 2007
- THE USE OF ELECTRICAL DEVICES FOR THE TREATMENT OF BLADDER DYSFUNCTION: A REVIEW OF METHODSJournal of Urology, 2004
- Intravesical electrical stimulation in the treatment of micturition dysfunction in childrenNeurourology and Urodynamics, 2003
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Conservative treatment of the neuropathic bladder in spinal cord injured patientsSpinal Cord, 2001